Christopher Klebanoff

Christopher Klebanoff is a cellular immunologist and medical oncologist with 17 years of experience in the preclinical and clinical development of T cell-based immunotherapies for the treatment of hematologic and solid cancers. Prior to joining Memorial Sloan Kettering, Christopher was an assistant clinical investigator and a NIH-Howard Hughes Medical Institute Research Scholar at the U.S. National Institutes of Health in Bethesda, Md. Christopher's laboratory investigations have contributed to the mechanistic understanding of how lymphodepletion enhances adoptive immunotherapies and how T cell differentiation status influences cellular persistence and clinical outcomes. Christopher completed his medical training at the Emory University School of Medicine and holds a B.S. in chemistry from Emory University.